MeiraGTx Holdings (MGTX) Net Cash Flow (QoQ) (2017 - 2025)
MeiraGTx Holdings (MGTX) Net Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 491.88% |
| Sep 30, 2025 | 66.96% |
| Jun 30, 2025 | -6.76% |
| Mar 31, 2025 | -81.71% |
| Dec 31, 2024 | -185.73% |
| Sep 30, 2024 | 223.14% |
| Jun 30, 2024 | -79.76% |
| Mar 31, 2024 | -116.58% |
| Dec 31, 2023 | 326.70% |
| Sep 30, 2023 | -218.46% |
| Jun 30, 2023 | 150.73% |
| Mar 31, 2023 | -63,921.62% |
| Dec 31, 2022 | -99.82% |
| Sep 30, 2022 | 200.97% |
| Jun 30, 2022 | -79.12% |
| Mar 31, 2022 | -344.91% |
| Dec 31, 2021 | 81.93% |
| Sep 30, 2021 | -9.10% |
| Jun 30, 2021 | -175.90% |
| Mar 31, 2021 | -132.54% |